Bath & Body Works saw its stock rise on a 'better than feared' earnings beat, but actual sales metrics remain soft. Investors remain cautious, looking for concrete signs of successful turnaround execution in the latter half of the year.
Podbit
From Bloomberg Intelligence · May 27, 2026
Bath & Body Works saw its stock rise on a 'better than feared' earnings beat, but actual sales metrics remain soft. Investors remain cautious, looking for concrete signs of successful turnaround execution in the latter half of the year.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.